{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:35:51Z","timestamp":1765827351047,"version":"build-2065373602"},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Appl. Oral Sci."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1590\/1678-775720140506","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T19:51:39Z","timestamp":1437594699000},"page":"310-314","source":"Crossref","is-referenced-by-count":13,"title":["Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking"],"prefix":"10.1590","volume":"23","author":[{"given":"Arezo","family":"TARDAST","sequence":"first","affiliation":[{"name":"Department of Oral & Maxillofacial Surgery, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reine","family":"SJ\u00d6MAN","sequence":"additional","affiliation":[{"name":"University Hospital, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigbj\u00f8rn","family":"L\u00d8ES","sequence":"additional","affiliation":[{"name":"Department of Oral & Maxillofacial Surgery, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahan","family":"ABTAHI","sequence":"additional","affiliation":[{"name":"University Hospital, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ijom.2013.02.007","article-title":"Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model","volume":"42","author":"Abtahi J","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-0714.2011.01125.x","article-title":"Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone","volume":"41","author":"Abtahi J","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1517\/14740338.5.6.743","article-title":"Osteonecrosis of the jaw: what do bisphosphonates do?","volume":"5","author":"Aspenberg P","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","article-title":"Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN","volume":"90","author":"Barasch A","year":"2011","journal-title":"J Dent Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1258\/175404507780796361","article-title":"Bisphosphonate-associated osteonecrosis of the jaw","volume":"13","author":"Basu N","year":"2007","journal-title":"Menopause Int"},{"key":"ref7","first-page":"265","article-title":"Evaluation of vascular endothelial growth factor (VEGF) in interradicular bone marrow in olpadronate treated animals","volume":"23","author":"Bigi MM","year":"2010","journal-title":"Acta Odontol Latinoam"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1056\/NEJMp068157","article-title":"Osteonecrosis of the jaw - do bisphosphonates pose a risk?","volume":"355","author":"Bilezikian JP","year":"2006","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson ER","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","article-title":"Bisphosphonates: clinical experience","volume":"9","author":"Coleman RE","year":"2004","journal-title":"Oncologist"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMcpc0800341","article-title":"Case records of the Massachusetts General Hospital. Case 9-2008. A 65-year-old woman with a non-healing ulcer of the jaw","volume":"358","author":"Dodson TB","year":"2008","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/0022034510387795","article-title":"ONJ in two dental practice-based research network regions","volume":"90","author":"Fellows JL","year":"2011","journal-title":"J Dent Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00432-010-0907-7","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases","volume":"136","author":"Filleul O","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.2010.05771.x","article-title":"Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients","volume":"1218","author":"Hoff AO","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3109\/00016357.2013.764007","article-title":"Bisphosphonate-related osteonecrosis of the jaw in four Nordic countries and an indication of under-reporting","volume":"71","author":"Kr\u00fcger TB","year":"2013","journal-title":"Acta Odontol Scand"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00784-011-0596-x","article-title":"Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap","volume":"16","author":"Lemound J","year":"2011","journal-title":"Clin Oral investing"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.joms.2011.02.059","article-title":"Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: a study of the changes in the jaws","volume":"69","author":"L\u00f3pez-Jornet P","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx RE","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate- associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki T","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","article-title":"Drug-induced osteoporosis: mechanisms and clinical implications","volume":"123","author":"Mazziotti G","year":"2010","journal-title":"Am J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1086\/648075","article-title":"Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces","volume":"49","author":"Naik NH","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw - 2014 update","volume":"72","author":"Ruggiero SL","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell RG","year":"1999","journal-title":"Bone"},{"key":"ref24","first-page":"1336","article-title":"Combined use of glucocorticoids and bisphosphonates may increase severity of bisphosphonate-related osteonecrosis of the jaw","volume":"505","author":"Rutkowski JL","year":"2011","journal-title":"J Oral Implantol"},{"key":"ref25","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenetic factors in cancer patients","volume":"8","author":"Santini D","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh PP","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.oraloncology.2008.04.013","article-title":"Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients","volume":"2","author":"Sonis ST","year":"2009","journal-title":"Oral Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"10","author":"Stopeck AT","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor KH","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","article-title":"Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy","volume":"65","author":"Wang EP","year":"2007","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Applied Oral Science"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jaos\/v23n3\/1678-7757-jaos-23-3-0310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T12:24:15Z","timestamp":1566995055000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1678-77572015000300310&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1678-77572015000300310"],"URL":"https:\/\/doi.org\/10.1590\/1678-775720140506","relation":{},"ISSN":["1678-7757"],"issn-type":[{"type":"electronic","value":"1678-7757"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}